This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Albendazole Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Capsule, Tablet); Application (Giardiasis, Trichuriasis, Filariasis, Neurocysticercosis, Hydatid Disease and Others)
Albendazole is a broad-spectrum anthelmintic. The principal mode of action for albendazole is by its inhibitory effect on tubulin polymerization which results in the loss of cytoplasmic microtubules. This drug is a medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken orally. The indication of drug is used for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the Taenia solium, pork tapeworm, and for the treatment of cystic hydatid disease of the lung, liver, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
MARKET DYNAMICS
The Albendazole Drug market is expected to grow significantly in the coming years, due to rising cases of neurocysticercosis (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems). Moreover, increasing health care expenditure anticipated to influence the end-user of Fujimycin.
MARKET SCOPE
The "Albendazole Drug Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Albendazole Drug market with detailed market segmentation by type and application. The Albendazole Drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Albendazole Drug market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Albendazole Drug market is segmented on the basis of type and application . Based on Type , the market is segmented into Tablet and Capsules. On the basis of application , the market is categorized as Giardiasis, Trichuriasis, Filariasis, Neurocysticercosis, Hydatid Disease and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Albendazole Drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Albendazole Drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Albendazole Drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Albendazole Drug market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the Albendazole Drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Albendazole Drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for Albendazole Drug in the global market. Below mentioned is the list of few companies engaged in the Albendazole Drug market.
The report also includes the profiles of key players in Albendazole Drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
GlaxoSmithKline
Hubei Zhongjia-Chem Pharmaceutical
Hubei Keyi Pharmaceutical
Changzhou Yabang
Huazhong Pharmaceutical
Sequent Scientific
K.A.Malle Pharmaceuticals
Fredun Pharmaceuticals
Ashish Life Science
AdvaCare Pharma
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Albendazole Drug Market - By Type
1.3.2 Albendazole Drug Market - By Application
1.3.3 Albendazole Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ALBENDAZOLE DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ALBENDAZOLE DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ALBENDAZOLE DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. ALBENDAZOLE DRUG - GLOBAL MARKET OVERVIEW
6.2. ALBENDAZOLE DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ALBENDAZOLE DRUG MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CAPSULE
7.3.1. Overview
7.3.2. Capsule Market Forecast and Analysis
7.4. TABLET
7.4.1. Overview
7.4.2. Tablet Market Forecast and Analysis
8. ALBENDAZOLE DRUG MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GIARDIASIS
8.3.1. Overview
8.3.2. Giardiasis Market Forecast and Analysis
8.4. TRICHURIASIS
8.4.1. Overview
8.4.2. Trichuriasis Market Forecast and Analysis
8.5. FILARIASIS
8.5.1. Overview
8.5.2. Filariasis Market Forecast and Analysis
8.6. NEUROCYSTICERCOSIS
8.6.1. Overview
8.6.2. Neurocysticercosis Market Forecast and Analysis
8.7. HYDATID DISEASE AND OTHERS
8.7.1. Overview
8.7.2. Hydatid Disease and Others Market Forecast and Analysis
9. ALBENDAZOLE DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Albendazole Drug Market Overview
9.1.2 North America Albendazole Drug Market Forecasts and Analysis
9.1.3 North America Albendazole Drug Market Forecasts and Analysis - By Type
9.1.4 North America Albendazole Drug Market Forecasts and Analysis - By Application
9.1.5 North America Albendazole Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Albendazole Drug Market
9.1.5.1.1 United States Albendazole Drug Market by Type
9.1.5.1.2 United States Albendazole Drug Market by Application
9.1.5.2 Canada Albendazole Drug Market
9.1.5.2.1 Canada Albendazole Drug Market by Type
9.1.5.2.2 Canada Albendazole Drug Market by Application
9.1.5.3 Mexico Albendazole Drug Market
9.1.5.3.1 Mexico Albendazole Drug Market by Type
9.1.5.3.2 Mexico Albendazole Drug Market by Application
9.2. EUROPE
9.2.1 Europe Albendazole Drug Market Overview
9.2.2 Europe Albendazole Drug Market Forecasts and Analysis
9.2.3 Europe Albendazole Drug Market Forecasts and Analysis - By Type
9.2.4 Europe Albendazole Drug Market Forecasts and Analysis - By Application
9.2.5 Europe Albendazole Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Albendazole Drug Market
9.2.5.1.1 Germany Albendazole Drug Market by Type
9.2.5.1.2 Germany Albendazole Drug Market by Application
9.2.5.2 France Albendazole Drug Market
9.2.5.2.1 France Albendazole Drug Market by Type
9.2.5.2.2 France Albendazole Drug Market by Application
9.2.5.3 Italy Albendazole Drug Market
9.2.5.3.1 Italy Albendazole Drug Market by Type
9.2.5.3.2 Italy Albendazole Drug Market by Application
9.2.5.4 Spain Albendazole Drug Market
9.2.5.4.1 Spain Albendazole Drug Market by Type
9.2.5.4.2 Spain Albendazole Drug Market by Application
9.2.5.5 United Kingdom Albendazole Drug Market
9.2.5.5.1 United Kingdom Albendazole Drug Market by Type
9.2.5.5.2 United Kingdom Albendazole Drug Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Albendazole Drug Market Overview
9.3.2 Asia-Pacific Albendazole Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Albendazole Drug Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Albendazole Drug Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Albendazole Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Albendazole Drug Market
9.3.5.1.1 Australia Albendazole Drug Market by Type
9.3.5.1.2 Australia Albendazole Drug Market by Application
9.3.5.2 China Albendazole Drug Market
9.3.5.2.1 China Albendazole Drug Market by Type
9.3.5.2.2 China Albendazole Drug Market by Application
9.3.5.3 India Albendazole Drug Market
9.3.5.3.1 India Albendazole Drug Market by Type
9.3.5.3.2 India Albendazole Drug Market by Application
9.3.5.4 Japan Albendazole Drug Market
9.3.5.4.1 Japan Albendazole Drug Market by Type
9.3.5.4.2 Japan Albendazole Drug Market by Application
9.3.5.5 South Korea Albendazole Drug Market
9.3.5.5.1 South Korea Albendazole Drug Market by Type
9.3.5.5.2 South Korea Albendazole Drug Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Albendazole Drug Market Overview
9.4.2 Middle East and Africa Albendazole Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Albendazole Drug Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Albendazole Drug Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Albendazole Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Albendazole Drug Market
9.4.5.1.1 South Africa Albendazole Drug Market by Type
9.4.5.1.2 South Africa Albendazole Drug Market by Application
9.4.5.2 Saudi Arabia Albendazole Drug Market
9.4.5.2.1 Saudi Arabia Albendazole Drug Market by Type
9.4.5.2.2 Saudi Arabia Albendazole Drug Market by Application
9.4.5.3 U.A.E Albendazole Drug Market
9.4.5.3.1 U.A.E Albendazole Drug Market by Type
9.4.5.3.2 U.A.E Albendazole Drug Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Albendazole Drug Market Overview
9.5.2 South and Central America Albendazole Drug Market Forecasts and Analysis
9.5.3 South and Central America Albendazole Drug Market Forecasts and Analysis - By Type
9.5.4 South and Central America Albendazole Drug Market Forecasts and Analysis - By Application
9.5.5 South and Central America Albendazole Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Albendazole Drug Market
9.5.5.1.1 Brazil Albendazole Drug Market by Type
9.5.5.1.2 Brazil Albendazole Drug Market by Application
9.5.5.2 Argentina Albendazole Drug Market
9.5.5.2.1 Argentina Albendazole Drug Market by Type
9.5.5.2.2 Argentina Albendazole Drug Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ALBENDAZOLE DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALBENDAZOLE DRUG MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. HUBEI ZHONGJIA-CHEM PHARMACEUTICAL
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. HUBEI KEYI PHARMACEUTICAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CHANGZHOU YABANG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. HUAZHONG PHARMACEUTICAL
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SEQUENT SCIENTIFIC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. K.A.MALLE PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. FREDUN PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ASHISH LIFE SCIENCE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ADVACARE PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
